Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Chrishan Samuel

20PUBLICATIONS
38CO-AUTHORS
MechanobiologyMolecular targetsRegenerative medicine (incl. stem cells)AutoimmunityProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

Sort by Publication Date:
|Jun 17, 2026
Therapeutic targeting of bleomycin-induced pulmonary fibrosis by human bone marrow mesenchymal stem cell-derived extracellular vesicles and/or pirfenidone: Impact of sex in mature adult mice.

|Jul 01, 2025
The novel AT2 receptor ligand, β-Pro7 Ang III, induces equivalent anti-fibrotic effects to Compound 21 but broader anti-fibrotic effects than pirfenidone in mice with bleomycin-induced pulmonary fibrosis.

Simon G Royce, Cem Erdem, WeiYi Mao

|Oct 24, 2024
The renoprotective efficacy and safety of genetically-engineered human bone marrow-derived mesenchymal stromal cells expressing anti-fibrotic cargo.

Yifang Li, Alex Hunter, Miqdad M Wakeel

|Apr 13, 2023
A Lipidated Single-B-Chain Derivative of Relaxin Exhibits Improved In Vitro Serum Stability without Altering Activity.

Praveen Praveen, Chao Wang, Thomas N G Handley

|Jan 30, 2023
Comparative Study of Ectopic Lymphoid Aggregates in Sheep and Murine Models of Bleomycin-Induced Pulmonary Fibrosis.

Udari Eshani Perera, Louise Organ, Simon G Royce

|Dec 23, 2022
Functional crosstalk between angiotensin receptors (types 1 and 2) and relaxin family peptide receptor 1 (RXFP1): Implications for the therapeutic targeting of fibrosis.

Chrishan S Samuel, Yifang Li, Yan Wang

Pageof 4

Frequent Collaborators

3 joint publications

Yan Wang

3 joint publications

Robert E Widdop

2 joint publications

Simon Royce

2 joint publications

Yifang Li

2 joint publications

Padma Murthi

1 joint publications

Habtamu B Derseh

1 joint publications

Antony Vinh

1 joint publications

Henry Diep

1 joint publications

Assam El-Osta

1 joint publications

Barbara K Kemp-Harper

Frequent Collaborators

3 joint publications

Yan Wang

3 joint publications

Robert E Widdop

2 joint publications

Simon Royce

2 joint publications

Yifang Li